$38.81
-0.01 (-0.03%)
Eli Lilly & Co. (NYSE:LLY)
CAPS Rating:
The Company discovers, develops, manufactures and sells products in one of its business segment of pharmaceutical products to prevent and treat human diseases.
RSS Headlines
Fool UK